Panayotopoulos Appointed Chairman and Interim Chief Executive Officer

CHICAGO--(BUSINESS WIRE)-- Dimitri Panayotopoulos has been appointed Coveris Chairman and Interim Chief Executive Officer by the Coveris Board of Directors, effective today. Dave Mezzanotte, who currently holds this position, announced his decision to retire and will assist in a transition period.

Dimitri has had a very distinguished career, including thirty-seven-years at Procter & Gamble where he led multiple businesses and served as Vice Chairman. During his time at P&G, Dimitri gained vast knowledge of best business practices across multiple geographies such as the U.K., Switzerland, Germany, Egypt, China and the USA, and many different categories. His acute knowledge of the fast-moving consumer goods market will prove invaluable in driving continued growth and commercial success at Coveris.

The Coveris Board would like to thank Dave for his many contributions to helping Coveris better serve the needs of our valued customers over the past four years.

ABOUT COVERIS

As a leading international manufacturing company, Coveris is dedicated to providing solutions that enhance the safety, quality and convenience of products we use every day. In partnership with the most respected brands in the world, Coveris develops vital products that protect everything from the food we eat, to medical supplies, to the touch screen device in our pockets, contributing to the lives of millions every day. Coveris is an affiliated portfolio company of Sun Capital Partners, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170911006246/en/

Coveris
Investor Relations:
Duane Owens, Treasurer, 864-641-4710
Mobile: 864-979-8593
[email protected]
or
Press:
Christopher Swalm, Corporate Marketing Communications Manager, 864-504-6145
Mobile: 864-415-8123
[email protected]
www.coveris.com

Source: Coveris

You May Also Be Interested In

• Elbit Systems to Report Second Quarter 2026 Financial Results on August 11, 2026
• Cardano Price Prediction: ADA Bulls Eye $1.50 Breakout While AlphaPepe Sells Token-Safety to Traders
• Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus